Tryggvason; Karl
Patent Applications and Registrations
Patent applications and USPTO patent grants for Tryggvason; Karl.The latest application filed is for "maintenance of differentiated cells with laminins".
Company Profile
6.34.38
- Tryggvason; Karl - Singapore SG
- Tryggvason; Karl - Djursholm SE
- Tryggvason; Karl - Stockholm SE
- Tryggvason; Karl - Oulu FI
- Tryggvason; Karl -
- Tryggvason; Karl - Djureholm SE
- Tryggvason; Karl - 90230 Oulu 23 FI
Patent Activity
| Patent | Date |
|---|---|
| Maintenance Of Differentiated Cells With Laminins App 20220041980 - Tryggvason; Karl ; et al. | 2022-02-10 |
| Maintenance of differentiated cells with laminins Grant 11,155,781 - Tryggvason , et al. October 26, 2 | 2021-10-26 |
| Differentiation Of Pluripotent Stem Cells And Cardiac Progenitor Cells Into Striated Cardiomyocyte Fibers Using Laminins Ln-511, Ln-521 And Ln-221 App 20210301257 - Tryggvason; Karl ; et al. | 2021-09-30 |
| Systems And Methods For Producing Retinal Progenitors App 20210189328 - Tryggvason; Karl ; et al. | 2021-06-24 |
| Methods Of Producing Rpe Cells App 20210139848 - Hovatta; Outi ; et al. | 2021-05-13 |
| Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins LN-511, LN-521 and LN-221 Grant 11,001,807 - Tryggvason , et al. May 11, 2 | 2021-05-11 |
| Methods of producing RPE cells Grant 10,889,801 - Hovatta , et al. January 12, 2 | 2021-01-12 |
| Composition and method for enabling proliferation of pluripotent human stem cells Grant 10,829,733 - Tryggvason , et al. November 10, 2 | 2020-11-10 |
| Methods For Culturing Human Keratinocytes App 20200071666 - Tryggvason; Karl ; et al. | 2020-03-05 |
| Differentiation Of Pluripotent Stem Cells And Cardiac Progenitor Cells Into Striated Cardiomyocyte Fibers Using Laminins Ln-511, Ln-521 And Ln-221 App 20190136190 - Tryggvason; Karl ; et al. | 2019-05-09 |
| Cell culture substrate comprising a laminin and a cadherin Grant 10,240,124 - Tryggvason , et al. | 2019-03-26 |
| Differentiation Of Pluripotent Stem Cells And Cardiac Progenitor Cells Into Striated Cardiomyocyte Fibers Using Laminins Ln-511, Ln-521 And Ln-221 App 20180362930 - Tryggvason; Karl ; et al. | 2018-12-20 |
| Cell culture medium Grant 10,138,292 - Tryggvason , et al. Nov | 2018-11-27 |
| Stem Cell Bank App 20170342378 - Tryggvason; Karl ; et al. | 2017-11-30 |
| Methods of enhancing genetic diagnosis Grant 9,828,630 - Tryggvason , et al. November 28, 2 | 2017-11-28 |
| Modulation Of Laminin Alpha-4 In The Prevention, Treatment, And Management Of Metabolic Syndromes App 20170216409 - Vaicik; Marcella K. ; et al. | 2017-08-03 |
| Stem cell bank Grant 9,719,066 - Tryggvason , et al. August 1, 2 | 2017-08-01 |
| Maintenance Of Differentiated Cells With Laminins App 20170067016 - Tryggvason; Karl ; et al. | 2017-03-09 |
| Isolated laminin-421 Grant 9,534,038 - Tryggvason , et al. January 3, 2 | 2017-01-03 |
| Maintenance of differentiated cells with laminins Grant 9,499,794 - Tryggvason , et al. November 22, 2 | 2016-11-22 |
| Differentiation Of Pluripotent Stem Cells And Cardiac Progenitor Cells Into Striated Cardiomyocyte Fibers Using Laminins Ln-511, Ln-521 And Ln-221 App 20160122717 - Tryggvason; Karl ; et al. | 2016-05-05 |
| Methods Of Producing Rpe Cells App 20150299653 - Hovatta; Outi ; et al. | 2015-10-22 |
| Stem Cell Bank App 20150191694 - Tryggvason; Karl ; et al. | 2015-07-09 |
| Chimeric Proteins For Treatment Of Diseases App 20150099297 - Tryggvason; Karl ; et al. | 2015-04-09 |
| Composition and method for enabling proliferation of pluripotent stem cells Grant 8,951,799 - Domogatskaya , et al. February 10, 2 | 2015-02-10 |
| Methods Of Enhancing Genetic Diagnosis App 20140349296 - Tryggvason; Karl ; et al. | 2014-11-27 |
| Cell Culture Substrate Comprising A Laminin And A Cadherin App 20140315306 - Tryggvason; Karl ; et al. | 2014-10-23 |
| Composition and method for enabling proliferation of pluripotent stem cells Grant 8,722,405 - Tryggvason , et al. May 13, 2 | 2014-05-13 |
| Maintenance Of Differentiated Cells With Laminins App 20130280750 - Tryggvason; Karl ; et al. | 2013-10-24 |
| Antibodies against domains of laminin-332 Grant 8,545,845 - Tryggvason , et al. October 1, 2 | 2013-10-01 |
| Recombinant laminin-521 Grant 8,415,156 - Tryggvason , et al. April 9, 2 | 2013-04-09 |
| Isolated Laminin-421 App 20120302512 - Tryggvason; Karl ; et al. | 2012-11-29 |
| Recombinant Laminin-521 App 20120156254 - TRYGGVASON; KARL ; et al. | 2012-06-21 |
| Cell Culture Medium App 20120156782 - Tryggvason; Karl ; et al. | 2012-06-21 |
| Antibodies Against Domains Of Laminin-332 App 20110243965 - Tryggvason; Karl ; et al. | 2011-10-06 |
| Composition and method for enabling proliferation of pluripotent stem cells App 20100323443 - Domogatskaya; Anna ; et al. | 2010-12-23 |
| Nephrin gene and protein Grant 7,799,529 - Tryggvason , et al. September 21, 2 | 2010-09-21 |
| Composition And Method For Enabling Proliferation Of Pluripotent Human Stem Cells App 20100203635 - Tryggvason; Karl ; et al. | 2010-08-12 |
| Composition And Method For Enabling Proliferation Of Pluripotent Stem Cells App 20080213885 - Tryggvason; Karl ; et al. | 2008-09-04 |
| Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis App 20070202111 - Tryggvason; Karl ; et al. | 2007-08-30 |
| Laminin chains: diagnostic uses App 20070077252 - Tryggvason; Karl ; et al. | 2007-04-05 |
| Laminin-5 gamma2-binding peptides, related compositions, and use thereof App 20070065447 - Tryggvason; Karl ; et al. | 2007-03-22 |
| Nephrin gene and protein App 20070009952 - Tryggvason; Karl ; et al. | 2007-01-11 |
| Glomerular expression profiling App 20060216722 - Betsholtz; Christer ; et al. | 2006-09-28 |
| Nephrin gene and protein Grant 7,105,291 - Tryggvason , et al. September 12, 2 | 2006-09-12 |
| Laminin chains: diagnostic uses Grant 6,955,924 - Tryggvason , et al. October 18, 2 | 2005-10-18 |
| Isolated laminin 10 Grant 6,933,273 - Tryggvason , et al. August 23, 2 | 2005-08-23 |
| Laminin chains: diagnostic and therapeutic use App 20050048518 - Tryggvason, Karl ; et al. | 2005-03-03 |
| Laminin chains: diagnostic uses App 20050019332 - Tryggvason, Karl ; et al. | 2005-01-27 |
| Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis App 20040120959 - Tryggvason, Karl ; et al. | 2004-06-24 |
| Perfusion apparatus and methods for pharmaceutical delivery Grant 6,689,090 - Tryggvason , et al. February 10, 2 | 2004-02-10 |
| Laminin 8 and methods for its use Grant 6,638,907 - Kortesmaa , et al. October 28, 2 | 2003-10-28 |
| Perfusion apparatus and methods for pharmaceutical delivery Grant 6,638,264 - Tryggvason , et al. October 28, 2 | 2003-10-28 |
| Laminin chains: diagnostic and therapeutic use App 20030100529 - Tryggvason, Karl ; et al. | 2003-05-29 |
| Isolated laminin 10 App 20030044899 - Tryggvason, Karl ; et al. | 2003-03-06 |
| Perfusion apparatus and methods for pharmaceutical delivery App 20020062121 - Tryggvason, Karl ; et al. | 2002-05-23 |
| Laminin chains: diagnostic uses App 20020052307 - Tryggvason, Karl ; et al. | 2002-05-02 |
| Nephrin gene and protein App 20020004589 - Tryggvason, Karl ; et al. | 2002-01-10 |
| Perfusion apparatus and methods for pharmaceutical delivery Grant 5,871,464 - Tryggvason , et al. February 16, 1 | 1999-02-16 |
| Laminin chains: diagnostic uses Grant 5,660,982 - Tryggvason , et al. August 26, 1 | 1997-08-26 |
| Basement membrane collagen degrading enzyme and method of purifying same Grant 4,816,400 - Tryggvason , et al. March 28, 1 | 1989-03-28 |
| Antibody composition for the detection of malignant cells with metastatic cell activity Grant 4,808,528 - Tryggvason , et al. February 28, 1 | 1989-02-28 |
| Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme Grant 4,677,058 - Tryggvason , et al. June 30, 1 | 1987-06-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 